Literature DB >> 12543712

An overview of the pathology and approaches to tissue engineering.

Erin R Ochoa1, Joseph P Vacanti.   

Abstract

In tissue engineering, there is an attempt to culture living tissues for surgical transplantation. In vitro and in vivo approaches have produced vascular and cardiovascular components, cartilage, bone, intestine, and liver. Attempts to microdesign cell-culture support scaffolds have used a new generation of biocompatible and bioabsorbable polymers. Suspensions of donor cells are seeded onto protein-coated polymer scaffolds and grown to confluence in dynamic bioreactors. In vitro techniques produce monolayers of tissues. Denser masses are achieved by implanting monolayers onto a host, or by culturing cell/polymer constructs in vivo. Existing techniques have produced functioning heart valves from sheep endothelial cells and myofibroblasts. Cultured ovine arterial cells have replaced 2-cm segments of pulmonary artery in lambs. Chondrocyte cultures have produced a human-ear-shaped construct, temporo-mandibular joint discs, meniscal replacement devices, and human-phalange-shaped constructs, complete with a joint. The culture of composite tissue types has recently been reported. Intestinal organoid units containing a mesenchymal core with surrounding polarized epithelia have been used in lieu of an ileal pouch in Lewis rats, and the long-term culture of rat hepatocytes has revealed cellular differentiation and neomorphology resembling elements of a biliary drainage system. To sustain the in vitro culture of dense tissues prior to implantation, micro-electro-mechanical systems (MEMS) fabrication technologies have been adapted to create wafers of polymer containing sealed, branching, vascular-type spaces. After seeding with rat lung endothelial cells, followed by 5 days of bioreactor culture, the result is an endothelial network with controlled blood flow rates, pressure, and hematocrit. When these customized vascular systems can be used to support in vitro culture, a new generation of dense, composite, morphologically complex tissues will be available for clinical development.

Entities:  

Mesh:

Year:  2002        PMID: 12543712     DOI: 10.1111/j.1749-6632.2002.tb04863.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  6 in total

1.  Tissue engineering using autologous microcirculatory beds as vascularized bioscaffolds.

Authors:  Edward I Chang; Robert G Bonillas; Samyra El-ftesi; Eric I Chang; Daniel J Ceradini; Ivan N Vial; Denise A Chan; Joseph Michaels; Geoffrey C Gurtner
Journal:  FASEB J       Date:  2008-11-10       Impact factor: 5.191

2.  Use of a novel joint-simulating culture system to grow organized ex-vivo three-dimensional cartilage-like constructs from embryonic epiphyseal cells.

Authors:  Ilan Cohen; Dror Robinson; Eitan Melamed; Zvi Nevo
Journal:  Iowa Orthop J       Date:  2005

3.  The surface molecular functionality of decellularized extracellular matrices.

Authors:  Christopher A Barnes; Jeremy Brison; Roger Michel; Bryan N Brown; David G Castner; Stephen F Badylak; Buddy D Ratner
Journal:  Biomaterials       Date:  2010-11-04       Impact factor: 12.479

Review 4.  Investigating monogenic and complex diseases with pluripotent stem cells.

Authors:  Hao Zhu; M William Lensch; Patrick Cahan; George Q Daley
Journal:  Nat Rev Genet       Date:  2011-03-09       Impact factor: 53.242

5.  Hemodynamic performance of tissue-engineered vascular grafts in Fontan patients.

Authors:  Erica L Schwarz; John M Kelly; Kevin M Blum; Kan N Hor; Andrew R Yates; Jacob C Zbinden; Aekaansh Verma; Stephanie E Lindsey; Abhay B Ramachandra; Jason M Szafron; Jay D Humphrey; Toshiharu Shin'oka; Alison L Marsden; Christopher K Breuer
Journal:  NPJ Regen Med       Date:  2021-07-22

6.  In vitro and in vivo effects of rat kidney vascular endothelial cells on osteogenesis of rat bone marrow mesenchymal stem cells growing on polylactide-glycoli acid (PLGA) scaffolds.

Authors:  Hongchen Sun; Zhe Qu; Ying Guo; Guangxiang Zang; Bai Yang
Journal:  Biomed Eng Online       Date:  2007-11-04       Impact factor: 2.819

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.